4 completed, 1 unknown. 3 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Kinki University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures EUS-guided choledocho-duodenostomy, Endoscopic retrograde cholangiopancreatography with covered metallic stent - Malignant Biliary Obstruction | Phase 2 / Phase 3 | Completed | Chinese University of Hong Kong | 77 | 2016-12-01 | 2023-08-31 |
| A Randomized Controlled Trial on EGBD vs PC for Acute Cholecystitis. EUS-guided gallbladder drainage (EGBD), Percutaneous cholecystostomy (PC) - Acute Cholecystitis | Phase 2 / Phase 3 | Completed | Chinese University of Hong Kong | 60 | 2014-08-01 | 2019-07-30 |
| Efficacy and Safety of Tamibarotene(AM80) for Lupus Nephritis Tamibarotene - Lupus Nephritis | Phase 2 | Unknown | Kinki University | 20 | 2010-09-01 | 2011-07-22 |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer peptide vaccine - Gastric Cancer | Phase 1 | Completed | Kinki University | 9 | 2008-09-01 | 2012-04-06 |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer URLC10 - Esophageal Cancer | Phase 1 | Completed | Kinki University | 7 | 2006-11-01 | 2012-04-06 |
Cholecystitis, Acute (1) · Esophageal Neoplasms (1) · Lupus Nephritis (1) · Stomach Neoplasms (1)
Cholangiopancreatography, Endoscopic Retrograde (1) · LY6K protein, human (1) · Protein Subunit Vaccines (1) · montanide ISA 51 (1) · tamibarotene (1)
Japan (5) · China (2) · Australia (1) · Belgium (1) · Denmark (1) · Spain (1)
Anthony Teoh, FRCSEd(Gen (1) · Hitoshi Shiozaki, MD (1)